UBE3A and colorectal carcinoma: NDRG2 was found to block UBE3A-mediated ubiquitination degradation of estrogen receptor beta (ERβ) by inhibiting the ability of UBE3A to combine with ERβ, thus playing a role in suppressing the proliferation of CRC cells [73].